Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors

Pharmazie

Volumn 59, Issue 10, 2004, Pages 739-743

  Obreza, A ^a   Stegnar, M ^b   Trampus Bakija A ^b   Prezeu A ^c   Urleb, Uroš ^a,c  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c Lek dd   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO [3 [[1 (1 AZEPANYLCARBONYL) 2 (2 NAPHTHOYL)HYDRAZINO]METHYL]PHENYL]METHANIMINIUM CHLORIDE; AZAPHENYLALANINE DERIVATIVE; BLOOD CLOTTING FACTOR 10A INHIBITOR; SERINE PROTEINASE INHIBITOR; THROMBIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MODIFICATION; IN VITRO STUDY; PROTEINASE INHIBITION;

CHROMATOGRAPHY, THIN LAYER; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PHENYLALANINE; SERINE PROTEINASE INHIBITORS; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZOLES; THROMBIN;

EID: 6344225687     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Coburn AC (2001) Small-molecule direct thrombin inhibitors. Exp Opin Ther Patents 11: 721-737.
2. Dahlbäck B (2000) Blood Coagulation. Lancet 355: 1627-1632.
3. Gresele P, Agnelli G (2002) Novel approaches to the treatment of thrombosis, trends pharmacol Sci 23: 25-32.
4. Hauptmann J, Stürzebecher J (1999) Synthetic inhibitors of thrombin and factor Xa: from bench to bedside. Thromb Res 93: 203-241.
5. Kimball SD (1995) thrombin active site inhibitors. Curr Pharm Des 1: 441-468.
6. Menear K (1998) Progress towards the discovery of orally active thrombin inhibitors. Curr Med Chem 5: 457-468.
7. Rai R, Sprengeler KC, Elrod KC, Young WB (2001) Perspectives on factor Xa inhibition. Curr Med Chem 8: 101-119.
8. Rewinkel JBM, Adang AEP (1999) Strategies and progress towards the ideal orally active thrombin inhibitor. Curr Pharm Des 5: 1043-1075.
9. Ripka WC (1997) New thrombin inhibitors in cardiovascular disease. Curr Opin Chem Biol 1: 242-253.
10. Sanderson PEJ (1999) Small, noncovalent serine protease inhibitors. Inc Med Res Rev 19: 179-197.
11. Vacca JP (2000) New advance in the discovery of thrombin and factor Xa inhibitors. Curr Opin Chem Biol 4: 394-400.
12. a. Farm Vestn 50: 53-57.
13. Zega A, Mlinšek G, Šepic P, Golič-Grdadolnik S, Šolmajer T, Tschopp TB, Steiner B, Kikelj D, Urleb U (2001a) Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization. Bioorg Med Chem 9: 2745-2756.
14. Zega A, Trampuš-Bakija A, Fortuna M, Stegnar M, Tschopp TB, Steiner B, Urleb U (2001b) Novel thrombin inhibitors with azaphenylalanine scaffold. Pharmazie 56: 683-685.